Cancer Research

Development of Novel Cathepsin V inhibitors to Validate role in Breast Cancer

Queen's University Belfast

School of Medicine, Dentistry and Biomedical Sciences

Location
Belfast, United Kingdom
Funding
See university guidance
Application deadline
See university guidance

About the project

The CCRCB Drug Discovery lab is focused on the development of highly potent, selective and drug-like lead compounds for the treatment of human diseases.

Working for PIs in the University we have developed a number of small molecule protease inhibitor tool compounds, that are currently being utilized to validate their target proteins as bone-fide drug targets.

  • Dr Richard Williams: School of Medicine, Dentistry and Biomedical Sciences

Contact info

  • View Academic Profile
  • askmhls@qub.ac.uk
  • +44 (0)28 9097 2791

Research Interests

Open to PhD applications in the field of

Make a PhD enquiry

  • MRes project: Development of Novel Cathepsin V inhibitors to Validate role in Breast Cancer
  • MRes project: Testing of Epigenetic Probes in Cancer Immune Cells
  • MRes project: Design, synthesis and SAR exploration of Novel LSD1 inhibitors

Public outreach & key achievements

  • Member of CRUK Accelerator Network Program in Structural Biology
  • Peer reviewer of Medicinal Chemistry Journals; Journal of Medicinal Chemistry, Bioorganic Medicinal Chemistry Letters and Journal of Pharmacy and Pharmacology
  • School Outreach program with Regent House School, Newtownards

Discover More

  • Faculty of Medicine, Health and Life Sciences
  • School of Medicine, Dentistry and Biomedical Science
  • The Patrick G Johnston Centre for Cancer Research

Research areas

Cancer ResearchMedicinal ChemistryCancer researchChemistryResearchCancer

Related PhD opportunities

PhD Cancer Research

Consensus subtyping of Prostrate Cancer

Queen's University Belfast

Consensus subtyping of Prostrate Cancer

Location
Belfast, United Kingdom
Deadline
See university guidance
Funding
See university guidance